Merck | MRK - Ebit

Aktienkurs
116.50
Täglich Wechseln
-0.85 -0.72%
Monatlich
-0.89%
Jährlich
1.30%
Q2 Prognose
114.30




Ebit Veränderung Datum
Adidas EUR 705M 541M 2026-03
Adyen EUR 627.12M 144.33M 2025-12
Akzo Nobel EUR 254M 37M 2026-03
Alcon AG USD 297M 20M 2026-03
Amadeus IT EUR 491.1M 152.2M 2026-03
Amarin USD -2.26M 564K 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
BASF EUR 1.4B 1.58B 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Beiersdorf EUR 504M 312M 2025-12
Covestro EUR -324M 5.72B 2025-12
Danone EUR 1.86B 48M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 268M 395M 2026-03
Genmab DKK 260M 199M 2025-12
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
GRIFOLS EUR 249M 103.11M 2026-03
Henkel EUR 1.42B 187M 2025-12
Hikma Pharmaceutical USD 348M 31M 2025-12
Infineon EUR 486M 75M 2026-03
Lakefront Biotherapeutics EUR -63.7M 844.26M 2026-03
Linde USD 2.25B 177M 2025-12
Lonza CHF 673M 54M 2025-06
Merck EUR 474M 738M 2025-12
Novartis USD 4.18B 118M 2026-03
Philips EUR 302M 417M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
UCB EUR 1.29B 571M 2025-12